The first order amounts to approximately SEK 10,000 and comes from a research customer with whom Lumito has previously collaborated. Within the scope of the earlier collaboration, the customer had the opportunity to evaluate the technology and is satisfied with the results. This has now led to a repeat purchase to enable continued research and further development of the project. The customer’s application places high demands on sensitivity, including the ability to analyse and identify rare cells.

The second order relates to a pilot study with an initial order value of approximately SEK 10,000-20,000, with the potential for additional revenue depending on the scope of future scanning. The dialogue with the customer has been ongoing since the third quarter of 2025, and the customer has now chosen to move forward by placing an order for a SCIZYS Erbium kit. As part of the pilot study, a limited number of initial scans are offered, after which the customer will transition to using Lumito’s Scan-as-a-Service offering. This project is also driven by the need for higher sensitivity than what established analytical methods can provide.

”That two additional Swedish research customers are now choosing to use our technology, one of them a returning customer, is a clear validation of the value of SCIZYS and our ability to meet needs where high sensitivity is critical. Scan-as-a-Service is an effective way for customers to get started with the technology and at the same time an important tool in our commercial development. Although the initial order values are limited, we see great potential in long-term collaborations and recurring revenue”, says Sanna Wallenborg, CEO of Lumito.